Welcome

The educational materials for patients and healthcare professionals included here are additional risk minimisation measures that are intended to support the safe and effective use of the medicinal product. Risk minimisation measures are a regulatory requirement and are part of the RMP (Risk Management Plans) approved by the EMA. They are assessed at national level by the HPRA for approval in Ireland.

Patient (or their caregiver)

The information on this web page is suitable for, and intended for, patients (or their caregivers) from Ireland prescribed this Teva medicine following consultation with healthcare professional.

Healthcare professionals

Information on this product is also available to healthcare professionals in Ireland.

Members of the public

For members of the public, we provide public reference information about the product.

Date of preparation: January 2025
Reference: D: GEN-IE-NP-00130 (V1.0) / T: GEN-IE-NP-00131 (V1.0) / M: GEN-IE-NP-00132 (V1.0)